Benzinga | Jul 31, 2020 06:43AM EDT

SVB Leerink Maintains Outperform on Seattle Genetics, Raises Price Target to $173

SVB Leerink analyst Andrew Berens maintains Seattle Genetics (NASDAQ:SGEN) with a Outperform and raises the price target from $167 to $173.